Acute onset dementia with COVID-19
Suggested citation:
Pishchikova LE, Letnikova ZV, Egorova DA. [Acute onset dementia with COVID-19]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2023;(1):60-68. Russian
In order to determine the ability of the COVID-19 virus to cause cognitive impairment and dementia in older people, a clinical case of acute onset dementia was analyzed. The review of pathogenesis factors that can cause the development of cognitive disfunction, including the direct impact of the virus on the structures of the brain, hypoxia, thrombosis, disorders of cerebral circulation is presented. A historical parallel with the exogenous types of K. Bonhoeffer reactions is drawn. We submit the results of studies of psychopathological manifestations of influenza psychoses in the past, which have not lost their relevance to the present. We note the special role of the form of disturbed consciousness characteristic of infectious and somatic psychoses – amentia. The sequential change of exogenous types of reactions that led to dementia is described.
Keywords older people; exogenous types of reactions; K. Bonhoeffer; neurotropism of the COVID-19 virus; disorders of consciousness; amentia; dementia with acute onset; mental disorders in influenza epidemics in a historical context
1. Otchet Pensionnogo fonda Rossii za 2021 god. URL: https://sfr.gov.ru/files/id/press_center/godovoi_otchet/Godovoy_otchet_PFR_-_2021.pdf (accessed on: 01.11.2022). (In Russ.) 2. Tanaka T, Okamoto S. Increase in suicide following an initial decline during the COVID-19 pandemic in Japan. Nat Hum Behav. 2021;5(2):229–38. DOI: https://doi.org/10.1038/s41562-020-01042-z 3. Mosolov SN. Problemy psikhicheskogo zdorov’ya v usloviyakh pandemii COVID-19. Zh Nevrol Psikhiatr Im SS Korsakova. 2020;120(5):7–15. (In Russ.) DOI: https://doi.org/10.17116/jnevro20201200517 4. Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020;87:34–9. DOI: https://doi.org/10.1016/j.bbi.2020.04.027 5. Galea S, Merchant RM, Lurie N. The mental health consequences of COVID-19 and physical distancing. The need for prevention and early intervention. JAMA Intern Med. 2020;180(6):817–8. DOI: https://doi.org/10.1001/jamainternmed.2020.1562 6. Bannikov GS, Milekhina AV, Pishchikova LE. Suicidal'noe povedenie v usloviyah pandemii COVID-19. Informacionnoe pis'mo. Moscow; 2021. 15 p. (In Russ.) 7. Alemanno F, Houdayer E, Parma A, et al. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience. PLoS One. 2021;16(2):e0246590. DOI: https://doi.org/10.1371/journal.pone.0246590 8. Jaywant A, Vanderlind WM, Alexopoulos GS, et al. Frequency and Profile of Objective Cognitive Deficits in Hospitalized Patients Recovering from COVID-19. Neuropsychopharmacology. 2021;46(13):2235–40. DOI: https://doi.org/10.1038/s41386-021-00978-8 9. Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611–27. DOI: https://doi.org/10.1016/S2215-0366(20)30203-0 10. Mosolov SN. Dlitel'nye psihicheskie narusheniya posle perenesennoj ostroj koronavirusnoj infekcii SARS-CoV-2. Sovremennaya terapiya psihicheskih rasstrojstv. 2021;(3):2–23. (In Russ.) DOI: https://doi.org/10.21265/PSYPH.2021.31.25.001 11. Mazza MG, de Lorenzo R, Conte C, et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594–600. DOI: https://doi.org/10.1016/j.bbi.2020.07.037 12. Taquet M, Geddes JR, Husain M, et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416–27. DOI: https://doi.org/10.1016/S2215-0366(21)00084-5 13. Beaud V, Crottaz-Herbette S, Dunet V, et al. Pattern of cognitive deficits in severe COVID-19. J Neurol Neurosurg Psychiatry. 2021;92(5):567–8. DOI: https://doi.org/10.1136/jnnp-2020-325173 14. Bonhoeffer K. Die symptomatischen Psychosen im Gufolge von akuten Infektionen und inneren Erkrankungen. Leipzig; Wien; 1910. 139 p. 15. Snezhnevskij AV. Pozdnie simptomaticheskie psihozy. Trudy Nevropsihiatricheskogo instituta im. P.B. Gannushkina. Moscow; 1940. Vol. 5. p. 156–275. (In Russ.) 16. Korsakov SS. K voprosu ob ostryh formah umopomeshatel'stva. Moscow; 1891. 12 p. (In Russ.) 17. Postovskij NP. Nervnye i dushevnye zabolevaniya pri inflyuence: Klinika. Obshhaja patologija. Lechenie. Doktorskaya dissertaciya. Moscow; 1904. 400 p. (In Russ.) 18. Naku AG. O psihozah pri epidemii grippa, vyzvannoj virusom A 2 v 1957 i 1959 godah. Infekcionnye psihozy. Trudy Kishinevskogo medicinskogo instituta. Vol. XV. Kishinev; 1961. p. 17–26. (In Russ.) 19. Gulyamov MG. Levinson YA. K. K ucheniyu o grippoznyh psihozah. Trudy Stalinabadskogo gosudarstvennogo medicinskogo instituta. 1959. Vol. 40, No 1. p. 75–108. (In Russ.) 20. Kahana TB. K voprosu o grippoznom encefalite. Infekcionnye psihozy. Trudy Kishinevskogo medicinskogo instituta. Vol. XV. Kishinev; 1961. р. 27–35. (In Russ.) 21. Molohov AN. Ob amencii i ee etiologicheskih variantah. Infekcionnye psihozy. Trudy Kishinevskogo medicinskogo instituta. Vol. XV. Kishinev; 1961. р. 125–33. (In Russ.) 22. Belopasov VV, Yachou Y, Samoilova EM, Baklaushev VP. The Nervous System Damage in COVID-19. Klinicheskaja praktika. 2020;11(2):60–80. (In Russ.) DOI: https://doi.org/10.17816/clinpract34851 23. Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8(2):130–40. DOI: https://doi.org/10.1016/S2215-0366(20)30462-4 24. Nakamura ZM, Nash RP, Laughon SL, Rosenstein DL. Neuropsychiatric Complications of COVID-19. Curr Psychiatry Reports. 2021;23(5):23–5. DOI: https://doi.org/10.1007/s11920-021-01237-9 25. Premraj L, Kannapadi NV, Briggs J. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci. 2022;434:120162. DOI: https://doi.org/10.1016/j.jns.2022.120162 26. La Hue SC, James TC., Newman JC, et al. Collaborative Delirium Prevention in the Age of COVID-19. J Am Geriatr Soc. 2020;68(5):947–9. DOI: https://doi.org/10.1111/jgs.16480.214 27. Misra S, Kolappa K, Prasad M. Frequency of Neurologic Manifestations in COVID-19: A Systematic Review and Meta-analysis. Neurology. 2021;97(23):e2269–81. DOI: https://doi.org/10.1212/WNL.0000000000012930 28. Reichard RR, Kashani KB, Boire NA, et al. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020;140(1):1–6. DOI: https://doi.org/10.1007/s00401-020-02166-2 29. Mao L, Jin H, Wang M. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):1–9. DOI: https://doi.org/10.1001/jamaneurol.2020.1127 30. Ellul MA., Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767–83. DOI: https://doi.org/10.1016/S1474-4422(20)30221-0 31. Kotfis K, Marra A, Ely EW. ICU delirium – a diagnostic and therapeutic challenge in the intensive care unit. Anaesthesiol Intensive Ther. 2018;50(2):160–7. DOI: https://doi.org/10.5603/AIT.a2018.0011 32. Alonso-Lana S, Marquie M, Ruiz A, Boada M. Cognitive and neuropsychiatric manifestations of COVID-19 and effects on elderly individuals with dementia. Front Aging Neurosci. 2020;12:588872. DOI: https://doi.org/10.3389/fnagi.2020.588872 33. Almeria M, Cejudo JC, Sotoca J, et al. Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health. 2020;9:100163. DOI: https://doi.org/10.1016/j.bbih.2020.100163 34. Luo W, Liu X, Bao K, Huang C. Ischemic stroke associated with COVID-19: a systematic review and meta-analysis. J Neurol. 2022;269(4):1731–40. DOI: https://doi.org/10.1007/s00415-021-10837-7 35. Pizova NV, Pizov NA, Skachkova OA, et al. [Acute Cerebral Circulatory Disorders and Coronavirus Disease]. Meditsinskiy sovet [Medical Council]. 2020;(8):18–25. (In Russ.) DOI: https://doi.org/10.21518/2079-701X-2020-8-18-25 36. Varatharaj A, Thomas N, Ellul MA, et al. Neurological and Neuropsychiatric Complications of COVID-19 in 153 Patients: A UK-Wide Surveillance Study. Lancet Psychiatry. 2020;7(10):875–82. DOI: https://doi.org/10.1016/S2215-0366(20)30287-X 37. Pendlebury ST, Rothwell PM. Incidence and Prevalence of Dementia Associated with Transient Ischaemic Attack and Stroke: Analysis of the Population-Based Oxford Vascular Study. Lancet Neurol. 2019;18(3):248–58. DOI: https://doi.org/10.1016/S1474-4422(18)30442-3 38. Mijajlović MD, Pavlović A, Brainin M, et al. Post-Stroke Dementia – A Comprehensive Review. BMC Med. 2017;15(1):11. DOI: https://doi.org/10.1186/s12916-017-0779-7 39. SHirokov EA. COVID-associirovannyj ishemicheskij insul't. Klinicheskaya medicina. 2020;98(5):375–7. (In Russ.) DOI: http://doi.org/10.30629/0023-2149-2020-98-5-375-377 40. Palmer JC, Tayler HM, Love S. Endothelin-converting enzyme-1 activity, endothelin-1 production, and free radical-dependent vasoconstriction in Alzheimer's disease. J Alzheimers Dis. 2013;36(3):577–87. DOI: https://doi.org/10.3233/JAD-13038
Article Metrics
Metrics powered by PLOS ALM